Breaking News - The Fly

Open Search

BGNE

BeiGene

$

()

BeiGene price target raised by $1 at TD Cowen, here's why

BGNE , NVS

Today - 07:26am

BeiGene receives European Commission approval for tislelizumab

BGNE

4/23/2024 - 06:06am

Drugmakers look to alternative suppliers after draft U.S. legislation, FT says

LLY , VRTX , BGNE

…

4/11/2024 - 06:23am

BeiGene price target lowered by $15 at BofA, here's why

BGNE

4/8/2024 - 09:03am

BeiGene price target lowered by $35 at Bernstein, here's why

BGNE

3/27/2024 - 06:16am

BeiGene price target lowered by $35 at Bernstein, here's why

BGNE

3/26/2024 - 20:57pm

JPMorgan biotech/pharma analysts hold an analyst/industry conference call

ABBV , ADCT , ALLO

…

3/15/2024 - 12:03pm

BeiGene receives FDA approval for Tevimbra

BGNE

3/14/2024 - 16:28pm

BeiGene gets approval for Tevimbra BLA

BGNE

3/14/2024 - 14:04pm

BeiGene announces first doses of Brukinsa administered

BGNE

3/13/2024 - 08:10am

BeiGene announces FDA accelerated approval of BRUKINSA

BGNE

3/7/2024 - 17:20pm

BeiGene announces new efficacy analysis comparing Brukinsa vs. Acalabrutinib

BGNE

2/29/2024 - 10:02am

BeiGene price target lowered by $5 at Guggenheim, here's why

BGNE

2/27/2024 - 07:41am

BeiGene price target raised by $11 at TD Cowen, here's why

BGNE

2/27/2024 - 07:25am

BeiGene's Biologics License Application for tevimbra accepted by FDA

BGNE

2/27/2024 - 06:19am